Glioblastoma multiforme (GBM) is the most malignant form of brain tumor, with limited therapeutic options. Different new therapeutic approaches will be presented, including angiogenesis inhibition and immunotherapy.

An overview of pediatric brain tumors and oligodendroglioma will be provided. Brain metastases are far more common than primary CNS tumors. The increase of brain metastases in cancer patients has drawn attention to this important, yet understudied, issue.

This conference will address description of the clinical problem, identification of the critical points of therapeutic failure and the state-of-the-art knowledge on the biology of brain metastases and on available treatments. Methodological research challenges in neuro-oncology will be discussed.

Learning objectives

• After attending this conference the learners will be able to:
• analyze currently available therapeutic options for GBM
• summarize current clinical practice in the management of pediatric brain tumors and oligodendroglioma
• illustrate novel therapeutic approaches for brain metastases
• discuss specific methodological research challenges in neuro-oncology.

For more information

For more information please download the brochure
 

Target audience
Neurologists, medical oncologists, radiation oncologists, neurosurgeons, neuropathologists, neuroradiologists with experience in brain tumors.

Accreditation
Serono Symposia International Foundation will submit this program “Central Nervous System (CNS) malignancies” to be held on October 25- 26, 2013 in Vienna, Austria for accreditation by the EACCME® and by ESMO®